Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenobarbital vs Ativan for Refractory Alcohol Withdrawal
NCT04156464Phase 4Unknown
- Sponsor
- OSF HealthCare
- Start
- Jul 2020
- Primary completion
- Dec 2021
- Modality
- Allosteric Modulators
- Countries
- 1
01
Overview
A Phase 4 trial of phenobarbital in alcohol withdrawal syndrome (AWS), sponsored by OSF HealthCare. Status: unknown.
02
Drugs
phenobarbital
03
Conditions
alcohol withdrawal syndrome (AWS)
Beyond the preview
Go deeper on NCT04156464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04156464.